Dr. S. Vincent Grasso is Global Practice Lead: Healthcare & Life Sciences at IPsoft. A trained surgeon, software architect, and business analyst, Dr. Grasso is actively engaged in shifting the delivery of healthcare from a centralized to a decentralized (distributed and mobile) environment through the optimization and integration of a unified communication platform. He aims to—among other things—enhance the patient experience, mitigate clinical risk, improve clinical outcomes, and provide healthcare systems with a competitive advantage via augmented revenue streams. In addition to leading IPsoft’s Healthcare & Life Sciences division, Dr. Grasso has held leadership positions within the public and private sector domestically and internationally. He received his MBA from the University of Massachusetts Amherst, MSIS from New Jersey Institute of Technology, DO from Des Moines University, surgical residency from the Mount Sinai School of Medicine Manhattan Program, advanced minimally invasive surgery fellowship from the Department of Surgery at Yale University, and advanced medical informatics related research and development at Yale NASA CSCMITA.
A conversational AI workforce provides a highly valuable addition to the existing ambulatory healthcare delivery team attempting to assist patients in following their care plans and gradually changing adverse patterns of behavior.
This global pandemic is by no means the first instance where AI has been used to analyze, track, predict and combat a threat. It is, however, the biggest and most global example of its use in tracking illness.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.